These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36815760)
1. Analysis of a Broad Range of Carbonyl Metabolites in Exhaled Breath by UHPLC-MS. Xie Z; Morris JD; Mattingly SJ; Sutaria SR; Huang J; Nantz MH; Fu XA Anal Chem; 2023 Mar; 95(9):4344-4352. PubMed ID: 36815760 [TBL] [Abstract][Full Text] [Related]
2. A novel microreactor approach for analysis of ketones and aldehydes in breath. Fu XA; Li M; Biswas S; Nantz MH; Higashi RM Analyst; 2011 Nov; 136(22):4662-6. PubMed ID: 21897949 [TBL] [Abstract][Full Text] [Related]
3. Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath. Xie Z; Morris JD; Pan J; Cooke EA; Sutaria SR; Balcom D; Marimuthu S; Parrish LW; Aliesky H; Huang JJ; Rai SN; Arnold FW; Huang J; Nantz MH; Fu XA Sci Rep; 2024 Jun; 14(1):14568. PubMed ID: 38914586 [TBL] [Abstract][Full Text] [Related]
4. Preconcentration and analysis of trace volatile carbonyl compounds. Li M; Biswas S; Nantz MH; Higashi RM; Fu XA Anal Chem; 2012 Feb; 84(3):1288-93. PubMed ID: 22145792 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive detection of lung cancer using exhaled breath. Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867 [TBL] [Abstract][Full Text] [Related]
6. Characterization of DNPH-coated microreactor chip for analysis of trace carbonyls with application for breath analysis. Chen Y; Li Q; Xie Z; Fu XA J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Feb; 1106-1107():58-63. PubMed ID: 30641269 [TBL] [Abstract][Full Text] [Related]
7. Identification of 2-alkenals, 4-hydroxy-2-alkenals, and 4-hydroxy-2,6-alkadienals in exhaled breath condensate by UHPLC-HRMS and in breath by real-time HRMS. García-Gómez D; Martínez-Lozano Sinues P; Barrios-Collado C; Vidal-de-Miguel G; Gaugg M; Zenobi R Anal Chem; 2015 Mar; 87(5):3087-93. PubMed ID: 25646646 [TBL] [Abstract][Full Text] [Related]
8. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
9. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath. Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Carbonyl Compounds in Ambient Air by a Microreactor Approach. Li M; Li Q; Nantz MH; Fu XA ACS Omega; 2018 Jun; 3(6):6764-6769. PubMed ID: 29978147 [TBL] [Abstract][Full Text] [Related]
11. Optimization of volatile organic compounds sampling from dairy cow exhaled breath using polymer-based solid-phase extraction cartridges for gas chromatographic analysis. Eichinger J; Reiche AM; Dohme-Meier F; Fuchsmann P J Breath Res; 2024 Apr; 18(3):. PubMed ID: 38547532 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease. Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599 [TBL] [Abstract][Full Text] [Related]
13. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
14. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study. Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338 [TBL] [Abstract][Full Text] [Related]
15. Analytical methodologies for broad metabolite coverage of exhaled breath condensate. Aksenov AA; Zamuruyev KO; Pasamontes A; Brown JF; Schivo M; Foutouhi S; Weimer BC; Kenyon NJ; Davis CE J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():17-25. PubMed ID: 28697414 [TBL] [Abstract][Full Text] [Related]
16. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related]
17. A feasibility study on exhaled breath analysis using UV spectroscopy to detect COVID-19. Sutaria SR; Morris JD; Xie Z; Cooke EA; Silvers SM; Long GA; Balcom D; Marimuthu S; Parrish LW; Aliesky H; Arnold FW; Huang J; Fu XA; Nantz MH J Breath Res; 2023 Nov; 18(1):. PubMed ID: 37875100 [TBL] [Abstract][Full Text] [Related]
18. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316 [TBL] [Abstract][Full Text] [Related]
19. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
20. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]